Crossed the 300 peer review publication mark recently #nomedicalwriters

Here is what I learned over 12 years of publishing

1. Don't include too many authors...
You have to type their name, affiliation AND email into those damn submission portals
God help 30+ collaborators!
2. Well, if someone is willing to submit the paper, maybe they do deserve to be a co-author after all
#letsnotbehasty
3. If the journal asks you to suggest reviewers, you will probably suggest people you think will like the paper or people who like you
#nohaters
4. You can never predict what people will like, and on second thought, you will regret picking those reviewers

Side note: most journals don't ask for suggestions
5. The only reviewer worse than someone who hates your guts is someone working on a similar idea or in a similar space
#stakesaresolow
6. The papers you think are brilliant and innovative get the most rejections, and the ones you think are obvious and dull get accepted right away

go figure
7. Journals are absolutely indifferent to time.

Editors don't even own watches, and can sit on a paper for months....

....but if you take more than 48 hours to approve the proof, they will end your life
7 cont.
You can be on vacation in the Amazon, but you are sure as shit better find a computer for those proofs

48 Hours!
8. Show me a person with 300 papers, and I will show you a person with 3000 rejections
9. Actually writing your own papers is hard
It is also cognitive work and can't be farmed out
#nomedicalwriters
10. The absolute best thing you can do in research is find someone smarter than you to work with.

A simple screening q: Do you think mild covid can reduce IQ by 10 pts?
11. The most important part of a research paper is the motivating idea

It has to be
A. Clever
B. Topical
C. Interesting no matter the result
D. Not too obvious/ hot (scoop-able)
12. Learning new methods and techniques, etc, etc. is all fine and good, but the most important thing to teach someone is how to come up with those ideas
12 cont...
If you are debating doing (insert degree) to help launch your research career, the right answer is "no"
Just find someone to work with, and start a project
On the job training
13. Open access fees can make your eyes pop out, but nothing is as expensive as paying a journal to review your paper and desk reject it. (Come on JCO, it's ridiculous)
14. Rest assured that, for at least one paper you published, the only person who read it in full is you...
or the medical writer.

But not your coauthors, reviewers or editor, and certainly no one else
15. No one ever let an unethical, delinquent control arm hold back their dream of a first author NEJM paper
16 If your research mentor hasn't published 10 papers in the last year, they need a research mentor, and you need a new one

(don't @ me; it's a joke; a true joke)
17. It's not all about the impact factor of the journal, but, also, most journals are literally read by no one.

If a tree falls in the forest and doesn't make a sound...

Try not to publish in journals you don't read.
18. One good paper is worth 1000 posters stuffed into tubes and collecting dust in your attic

or 1 poster taking up the overhead bin space when I have a carry on
19. If you get bored yourself in the middle of research project, abandon ship b/c no one else will be interested
20. Twitter is fun, tweetorials are neat, youtube is lovely, podcasting amazing, op-ed writing a delight....
but no one is really going to consider that scholarship anytime soon, and careers are made off of papers

It's true, sorry
21. You don't have to publish academic papers to know what you are talking about, but it helps
22. If you don't actually believe your result is true because you know how the sausage was made
...
....
....
don't publish the result
23. The only thing worse than a collaborator who gives too few edits is one who gives too many
24. If you didn't find this funny, then you are doomed; sorry to say

But jokes aside, if anyone wants sincere advice contact me here
vinayakkprasad.com/contact
Turned it into a video for those interested
25. Uh oh, years of cutting off authors past 4 has caught up with me!!

Sorry, I thought your name was Et. al.

Poor sense of humor & poor reading comprehension!

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Vinay Prasad, MD MPH 🎙️📷

Vinay Prasad, MD MPH 🎙️📷 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @VPrasadMDMPH

31 Jul
The idea that Delta somehow changes the risk benefit for kids attending school is literally the dumbest idea I've heard

Unless a new variant has an IFR 10-fold higher in that age group, the net benefit is to continue school in person

School has mental and physical benefits
It has benefits on upward mobility, socioeconomic status, equality, civics, society.
It was always a bad idea to close schools. It was a forgivable bad idea in the spring of 2020. By the fall of 2020, the data were clear and it was no longer a forgivable mistake. By 2021 It's criminal to keep it closed any longer
Read 7 tweets
29 Jul
I hope real experts in EBM know that the idea cloth masks "work" on vaccinated people with >50/100k cases SUMMED over 7 days with delta, but not pre-delta, & not at lower case rates, is actually....

100% MADE UP
Like, I hope that masks have not been so politicized and so linked to virtue that the last intelligent person in biomedicine actually thinks this is evidence based anything
Instead, what it is is the APPEARANCE of doing something, as we wait for the inevitable break in the pandemic trajectory
Read 7 tweets
29 Jul
I appreciate this thread by @SarahKarlin an excellent biotech/ regulatory reporter

Some thoughts on Pazdur's comments [thread]
First, all this fiasco is due to Rick himself!
STAT reports that he advised FDA to approve aduhelm by AA, which drew attention to the pathway

The pathway had been abused for years in cancer, but few cared; now all eyes on it.

He has only himself to blame for the attention!!
Next, as background. FDA lets cancer drugs come to market that improve survival AND some that shrink tumors (RR) or slow their growth past arbitrary thresholds (PFS)

The ratio is what, would you guess?
5:1?
4:1?
....
Read 15 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(